Table 2 Collection of individual data according to the children schedule at the AIRE research sites
Inclusion All IMCI eligible consultation at PHC level | If hospitalized, recommended for all severe cases (respiratory and non-respiratory cases) | Follow-up visit: at the PHC, telephone call or home visit All severe cases regardless of hospitalization | ||
|---|---|---|---|---|
D-0 | Entry | Discharge | Day-14 (+ 14 days) | |
Inclusion criteria Informed consent | ✓ | |||
Socio-demographic characteristics, care pathway before attending PHC, IMCI classification | ✓ | |||
Medical history and treatment | ✓ | |||
Clinical examination (symptoms and signs) a | ✓ | ✓ | ✓ | |
Co-morbidities (malnutrition, anemia, malaria) | ✓ | ✓ | ||
SpO2 Measurement by PO and integration into the IMCI classification (severe case if SpO2 < 90%) | ✓ | ✓ | ✓ | |
Use of Malaria Rapid Diagnostic Test (RDT) | ✓ | ✓ | ||
Medical treatment (antibiotics, artemisinin -based combination treatment, salbutamol, etc.) | ✓ | ✓ | ✓ | |
Hospital referral decision for severe cases | ✓ | |||
Missed opportunities of referral for severe cases and reasons | ✓ | |||
Oxygen therapy | ✓ | ✓ | ||
Laboratory evaluation, (full blood count, malaria RDT…) if applicable | ✓ | |||
Evaluation of response to treatment | ✓ | ✓ | ||
Treatment and management of comorbidities | ✓ | ✓ | ||
Costs (households, and government perspective) b | ✓ | ✓ | ✓ | ✓ |
Vital status | ✓ | ✓ | ||